comscore2014 San Antonio Breast Cancer Symposium Research Highlights

2014 San Antonio Breast Cancer Symposium Research Highlights

Brian Wojciechowski, MD, discusses research presented at the 2014 San Antonio Breast Cancer Symposium
Oct 19, 2016
00:00
Download
00:00

In this Breastcancer.org podcast, Dr. Brian Wojciechowski discusses some of the research that was presented at the 2014 San Antonio Breast Cancer Symposium.

Listen to the podcast to hear Dr. Wojciechowski explain:

  • results of a study that found that Aromasin plus ovarian suppression reduced recurrence risk better than tamoxifen plus ovarian suppression in some women diagnosed with early-stage, hormone-receptor-positive disease

  • research that underscored the long-term benefits of tamoxifen for reducing risk in women with a higher-than-average risk of breast cancer who’ve never been diagnosed

  • a study showing that Faslodex worked better than Arimidex as a first treatment for women newly diagnosed with advanced-stage breast cancer

  • research conducted in part by Breastcancer.org that shows that breastfeeding, even for a short time, reduces breast cancer risk more than previously thought

  • why a low-fat diet improved survival in women diagnosed with hormone-receptor-negative breast cancer

About the guest
 
Brian Wojciechowski headshot
Brian Wojciechowski, MD

Dr. Wojo is a medical oncologist outside of Philadelphia, PA, with Crozer Health. His research has been presented at the San Antonio Breast Cancer Symposium, and he is a speaker on medical ethics and the biology of cancer. Dr. Wojo sees cancer as a scientifically complex disease with psychological, social, and spiritual dimensions.

— Last updated on June 29, 2022, 2:46 PM

 
 
Support Breastcancer.org to produce more content like this

Your donation goes directly to what you read, hear, and see on Breastcancer.org.

Donate